We are live on
!
Find out more
MDSL
M.D. Sass LLC Portfolio holdings
AUM
$1.32B
1-Year Est. Return
16.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$1.14B
AUM Growth
-$193M
(-15%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-15.81%
Top 10 Holdings %
Top 10 Hldgs %
55.81%
Holding
40
New
6
Increased
10
Reduced
16
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$71.3M |
| 2 |
Quanta Services
PWR
|
+$59.9M |
| 3 |
Williams Companies
WMB
|
+$56.1M |
| 4 |
Capital One
COF
|
+$46M |
| 5 |
SLM Corp
SLM
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$72.3M |
| 2 |
Marvell Technology
MRVL
|
+$66.2M |
| 3 |
Becton Dickinson
BDX
|
+$63.7M |
| 4 |
SBA Communications
SBAC
|
+$59.3M |
| 5 |
CACI
CACI
|
+$49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 27.22% |
| 2 | Financials | 25.3% |
| 3 | Technology | 10.06% |
| 4 | Real Estate | 10.04% |
| 5 | Healthcare | 5.65% |
Similar funds
LCS
CC
CP
IEFM
GSEP
TIM
MCM
HCM
M.D. Sass LLC's Q1 2025 Portfolio in Review
As of Q1 2025, M.D. Sass LLC held 40 positions worth $1.14B, down 15% from $1.33B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
M.D. Sass LLC withdrew a net $180M in Q1 2025, closing 8 positions and reducing 16 holdings. Its most notable exit was Charles River Laboratories, an estimated $72.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 21% a quarter earlier, followed by Financials and Technology.
Against the trend, M.D. Sass LLC opened a new position in Amphenol worth $68.6M.
- M.D. Sass LLC's largest Q1 2025 buy was Amphenol: 1,045,366 shares worth $68.6M.
- M.D. Sass LLC added most to Danaher in Q1 2025, an estimated $34.4M increase.
- M.D. Sass LLC's biggest Q1 2025 reduction was CACI, cutting an estimated $49M.
- M.D. Sass LLC fully exited Charles River Laboratories in Q1 2025, selling an estimated $72.3M.
- M.D. Sass LLC's ten largest holdings make up 56% of its $1.14B portfolio in Q1 2025.
- M.D. Sass LLC opened 6 new positions and closed 8 in Q1 2025.
- M.D. Sass LLC's portfolio value fell 15% quarter-over-quarter to $1.14B.
Based on M.D. Sass LLC's 13F filing for Q1 2025, filed 9 May 2025.